Modelling for cost-effectiveness analysis.
Modelling for cost-effectiveness analysis.
复制标题
成本效益分析建模。
DOI：
--
复制
发表时间：
1999
影响因子：
2
通讯作者：
Louise B. Russell
中科院分区：
文献类型：
--
作者：
Louise B. Russell
模型创建了成本效益分析框架，使决策者能够探索在不同条件下以不同方式使用干预措施的影响。为了达到其目的，模型必须产生准确的预测，并考虑到影响成本和效果的因素存在很大的变化。本文考虑了建模的三个方面：验证有效性估计；建模成本；以及常见统计形式的影响。针对成本提出了类似于有效性估计的验证程序。建模者需要更加注意确保模型描述的事件路径既能体现成本，又能体现效果。建模者还可以通过显示这些领域传统使用的统计形式对资源分配的影响，帮助改进成本效益分析所依赖的流行病学和临床研究。
A model creates the framework for a cost-effectiveness analysis, allowing decision makers to explore the implications of using an intervention in different ways and under different conditions. To serve its purpose a model must produce accurate predictions and allow for substantial variation in the factors that influence costs and effects. This paper considers three aspects of modelling: validating effectiveness estimates; modelling costs; and the implications of common statistical forms. Validation procedures similar to those for effectiveness estimates are proposed for costs. Modellers need to pay more attention to ensuring that the pathway of events described by a model represents costs as well as it does effects. Modellers can also help improve the epidemiological and clinical research on which cost-effectiveness analyses depend by showing the implications for resource allocation of the statistical forms conventionally used in these fields.
用于预防静脉注射艾滋病的漂白剂计划
影响因子：
12.7
作者：
Siegel,JE;Weinstein,MC;Fineberg,HV
通讯作者：
Fineberg,HV
评估老年人心血管疾病危险因素影响的风险比和风险差异。
影响因子：
7.2
作者：
Psaty,BM;Koepsell,TD;Manolio,TA;LongstrethJr,WT;Wagner,EH;Wahl,PW;Kronmal,RA
通讯作者：
Kronmal,RA
影响因子：
158.5
作者：
LEWIS, EJ;HUNSICKER, LG;ROHDE, RD
通讯作者：
ROHDE, RD